comparemela.com

Page 8 - Curis Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Curis (CRIS) Enters into Agreement for Emavusertib / Pembrolizumab Combination Study in Melanoma

Curis (CRIS) Enters into Agreement for Emavusertib / Pembrolizumab Combination Study in Melanoma
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Why Genesco Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday s Mid-Day Session - Aditxt (NASDAQ:ADTX), Altimmune (NASDAQ:ALT)

Curis (NASDAQ:CRIS) Now Covered by Analysts at Truist Financial

Curis (NASDAQ:CRIS) Now Covered by Analysts at Truist Financial
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

Curis, Inc (NASDAQ:CRIS) Sees Significant Increase in Short Interest

Curis, Inc. (NASDAQ:CRIS – Get Free Report) saw a large growth in short interest during the month of October. As of October 31st, there was short interest totalling 83,100 shares, a growth of 13.2% from the October 15th total of 73,400 shares. Based on an average daily trading volume, of 24,400 shares, the days-to-cover ratio […]

Curis s stock rises as analysts see the next Pharmacyclics

Shares of Curis Inc. CRIS, gained nearly 6% premarket on Friday after Truist Securities analysts initiated coverage of the cancer-focused biotech company with…

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.